1. Plasmablastic lymphoma of the gallbladder

   • Yoshinobu Konishi
   • Hitomi Kaneko
   • Kazunori Imada

   Images in Hematology 08 April 2016 Pages: 1 - 3

   

2. Current status and recent advances of gene therapy in hematological diseases

   • Masato Yamamoto
   • Kenzaburo Tani

   Progress in Hematology 01 June 2016 Pages: 4 - 5

3. Biology and clinical application of CAR T cells for B cell malignancies

   • Marco L. Davila
   • Michel Sadelain

   Progress in Hematology 04 June 2016 Pages: 6 - 17

   

4. Gene editing and its application for hematological diseases

   • Mark J. Osborn
   • Joseph J. Belanto
   • Daniel F. Voytas

   Progress in Hematology 27 May 2016 Pages: 18 - 28

   

5. Gene and virotherapy for hematological malignancies

   • Evidio Domingo-Musibay
   • Masato Yamamoto

   Progress in Hematology 11 June 2016 Pages: 29 - 41

   

6. Current status of ex vivo gene therapy for hematological disorders: a review of clinical trials in Japan around the world

   • Kenzaburo Tani

   Progress in Hematology 11 June 2016 Pages: 42 - 72

7. Regulatory approval pathways for anticancer drugs in Japan, the EU and the US

   • Sumimasa Nagai
   • Keiya Ozawa

   Review Article 15 April 2016 Pages: 73 - 84

8. Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles

   • Emilie Reboursiere
   • H. Fouques
   • S. Cheze

   Original Article 04 April 2016 Pages: 85 - 91

9. Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution

   • Hae Tha Mya
   • Hui Ming Tay
   • Heng Joo Ng

   Original Article 22 April 2016 Pages: 92 - 98

10. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study

    • Akira Morimoto
    • Yoko Shioda
    • Shinsaku Imashuku

    Original Article 04 April 2016 Pages: 99 - 109

    

11. Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding

    • Hirofumi Nakano
    • Masahiro Ashizawa
    • Yoshinobu Kanda

    Original Article 15 April 2016 Pages: 110 - 116

    

12. Reduced-dose methotrexate in combination with tacrolimus was associated with rapid engraftment and recovery from oral mucositis without affecting the incidence of GVHD

    • Toshihiro Matsukawa
    • Daigo Hashimoto
    • Takanori Teshima

    Original Article 27 April 2016 Pages: 117 - 124

    

13. PIEZO1 gene mutation in a Japanese family with hereditary high phosphatidylcholine hemolytic anemia and hemochromatosis-induced diabetes mellitus

    • Shinsaku Imashuku
    • Hideki Muramatsu
    • Hitoshi Kanno

    Case Report 14 March 2016 Pages: 125 - 129

    

14. Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia

    • Kyogo Suzuki
    • Hideki Muramatsu
    • Seiji Kojima

    Case Report 23 April 2016 Pages: 130 - 133

15. Transient ischemic attack as an unusual initial manifestation of acute promyelocytic leukemia

    • Lifeng Liu
    • Xiaoling Yuan

    Case Report 16 March 2016 Pages: 134 - 138

    

16. Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature

    • Takeo Sarashina
    • Haruko Iwabuchi
    • Hiroaki Goto

    Case Report 18 March 2016 Pages: 139 - 143

17. Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia: should this be the first choice to establish the diagnosis of APL?

    • Emanuele Ammatuna

    Letter to the Editor 02 April 2016 Pages: 144 - 145